|
|
Volumn 21, Issue 5, 2014, Pages 409-414
|
|
Immunotherapy for Graves' ophthalmopathy
a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLOCKING ANTIBODY;
MONOCLONAL ANTIBODY;
RITUXIMAB;
SOMATOMEDIN C RECEPTOR;
TUMOR NECROSIS FACTOR ALPHA;
ANTAGONISTS AND INHIBITORS;
DRUG EFFECTS;
FIBROBLAST;
GRAVES OPHTHALMOPATHY;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
INFLAMMATION;
PROCEDURES;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
T LYMPHOCYTE;
ANTIBODIES, BLOCKING;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
FIBROBLASTS;
GRAVES OPHTHALMOPATHY;
HUMANS;
IMMUNOTHERAPY;
INFLAMMATION;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECEPTOR, IGF TYPE 1;
T-LYMPHOCYTES;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 85027957758
PISSN: None
EISSN: 17522978
Source Type: Journal
DOI: 10.1097/MED.0000000000000097 Document Type: Review |
|
Times cited : (35)
|
|
References (0)
|